This topic contains a solution. Click here to go to the answer

Author Question: As with Saturn's F ring, shepherd moons play a major role in the structure of the thin narrow rings ... (Read 64 times)

TFauchery

  • Hero Member
  • *****
  • Posts: 500
As with Saturn's F ring, shepherd moons play a major role in the structure of the thin narrow rings around Uranus.
 
  Indicate whether the statement is true or false

Question 2

Star A is a main sequence star of spectral type G5 and star B is a red giant of spectral type K2. Which statement below is correct?
 
  A) Star A appears brighter than star B.
  B) Star B appears brighter than star A.
  C) Star A is hotter than star B.
  D) Star B is hotter than star A.
  E) None of the above can be said about these two stars.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mcinincha279

  • Sr. Member
  • ****
  • Posts: 316
Answer to Question 1

TRUE

Answer to Question 2

C




TFauchery

  • Member
  • Posts: 500
Reply 2 on: Jul 27, 2018
Great answer, keep it coming :)


recede

  • Member
  • Posts: 315
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Limit intake of red meat and dairy products made with whole milk. Choose skim milk, low-fat or fat-free dairy products. Limit fried food. Use healthy oils when cooking.

Did you know?

Though “Krazy Glue” or “Super Glue” has the ability to seal small wounds, it is not recommended for this purpose since it contains many substances that should not enter the body through the skin, and may be harmful.

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library